Skip to main content
AAN.com
Articles
December 1, 1997

Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale

December 1997 issue
49 (6) 1580-1587

Abstract

We evaluated the ability of nurse clinicians to assess parkinsonian signs in older persons with a modified version of the motor section of the Unified Parkinson's Disease Rating Scale (UPDRS). After completing a structured training protocol, three nurse clinicians and a neurologist with expertise in movement disorders administered a modified UPDRS to 75 older persons. The nurses repeated the assessment about 3 weeks later. Inter-rater agreement and short-term temporal stability were estimated for each item, the total modified UPDRS score, and for summary measures of bradykinesia, postural reflex impairment, rigidity, and tremor, and a global parkinsonian sign score. We performed our assessment in Catholic religious communities in the Chicago area, using consecutive subjects at four communities participating in the Religious Orders Study, a longitudinal, clinical-pathologic study of older persons. Our results showed that nurses were not a significant source of variability, with intraclass correlations exceeding 0.97 for all items, and they showed good to excellent agreement with the neurologist for most modified UPDRS items. Correlations between nurses and neurologist exceeded 0.90 for the total modified UPDRS, ranged from 0.76 to 0.95 for the four parkinsonian domain scores, and exceeded 0.90 for the global parkinsonian sign score. Nurses showed fair to good agreement with themselves over the 3-week interval for most modified UPDRS items. Correlations over the 3-week interval exceeded 0.90 for the total modified UPDRS score, ranged from 0.70 to 0.95 for the four domain scores, and exceeded 0.90 for the global parkinsonian sign score. Ratings of parkinsonian signs by nurse clinicians corresponded closely to those of a neurologist with expertise in movement disorders and showed good inter-rater agreement and temporal stability. With appropriate training, nurse clinicians can reliably administer the modified UPDRS.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Barbeau A. Aging and the extrapyramidal system. J Am Geriatr Soc 1973;21:145-149.
2.
Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
3.
Galasko D, Kwo-on-Yuen PF, Klauber MR, Thal LJ. Neurological findings in Alzheimer's disease and normal aging. Arch Neurol 1990;47:625-627.
4.
Kaye JA, Oken BS, Howieson DB, Howieson J, Holm LA, Dennison K. Neurologic evaluation of the optimally healthy oldest old. Arch Neurol 1994;51:1205-1211.
5.
Kokmen E, Bossemeyer RW, Barney J, Williams W. Neurological manifestations of aging. J Gerontol 1977;32:411-419.
6.
Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationship between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Ann Neurol 1993;33:267-274.
7.
Waite LM, Broe GA, Creasey H, Grayson D, Edelbrock D, O'Toole B. Neurological signs, aging, and the neurodegenerative syndromes. Arch Neurol 1996;53:498-502.
8.
Calne DB, Eisen A, Meneilly G. Normal aging of the nervous system. Ann Neurol 1991;30:206-207.
9.
Katzman R, Terry R. Normal aging of the nervous system. In: Katzman R, Rowe JW, eds. Principles of geriatric neurology. Philadelphia: F.A. Davis, 1992:18-58.
10.
Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs and incident dementia: follow-up analysis. Neurology 1995;45:1942.
11.
Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent developments in Parkinson's disease, vol 2. Florham Park, NJ: MacMillan Healthcare Information, 1987:153-163.
12.
CAPIT Committee: Langston JW, Widner H, Goetz CG, et al. Core assessment program of intracerebral transplantation. Mov Disord 1992;7:2-13.
13.
de Rijk MC, Breteler MMB, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam study. Neurology 1995;45:2143-2146.
14.
Martinez-Martin P, Bermejo-Pareja F. Rating scales in Parkinson's disease. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Urban & Schwarzenberg, 1988:235-242.
15.
Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992;49:492-497.
16.
Parkinson Study Group. Effects of tocopherol and Deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1993;328:176-183.
17.
Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a baseline analysis of the DATATOP cohort. Neurology 1990;40:1529-1534.
18.
Folstein MF, Folstein SE, McHugh PR. `Mini-mental state': a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19.
Clark CM, Ewbank D, Lerner A, et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study. Neurology 1997;49:70-75.
20.
Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the Unified Parkinson's Disease Rating Scale. Mov Disord 1995;10:263-266.
21.
Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley & Sons, 1981.
22.
Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ. Which clinical signs of Parkinson's disease best reflect the nigrostriatal lesion? Ann Neurol 1997;41:58-64.
23.
Hershey LA, Feldman BJ, Kim KY, Commichau C, Lichter DG. Tremor at onset: predictor of cognitive and motor outcome in Parkinson's disease. Arch Neurol 1991;48:1049-1051.
24.
Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985;35:522-526.
25.
Gerlach J, Korsgaard S, Clemmesen P, et al. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand 1993;87:244-252.
26.
Ginanneschi A, Degl'Innocenti F, Magnolfi S, et al. Evaluation of Parkinson's disease: reliability of three rating scales. Neuroepidemiology 1988;7:38-41.
27.
Hely MA, Chey T, Wilson A, et al. Reliability of the Columbia Scale for assessing signs of Parkinson's disease. Mov Disord 1993;8:466-472.
28.
Henderson L, Kennard C, Crawford TJ, et al. Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity. J Neurol Neurosurg Psychiatry 1991;54:18-24.
29.
Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 1994;9:76-83.
30.
Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 1994;9:89-91.
31.
Richards M, Marder K, Bell K, Dooneief G, Mayeux R, Stern Y. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol 1991;48:1147-1149.
32.
Sweet RA, DeSensi EG, Zubenko GS. Reliability and applicability of movement disorder rating scales in the elderly. J Neuropsychiatry Clin Neurosci 1993;5:56-60.
33.
Geminiani G, Cesana BM, Tamma F, et al. Interobserver reliability between neurologists in training of Parkinson's disease rating scales: a multicenter study. Mov Disord 1991;6:330-335.
34.
Rajput AH, Rozdilsky B, Ang L. Occurrence of resting tremor in Parkinson's disease. Neurology 1991;41:1298-1299.

Information & Authors

Information

Published In

Neurology®
Volume 49Number 6December 1997
Pages: 1580-1587
PubMed: 9409350

Publication History

Published online: December 1, 1997
Published in issue: December 1997

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

D. A. Bennett, MD
From the Rush Alzheimer's Disease Center (Drs. Bennett and Wilson), Rush Institute for Healthy Aging (Drs. Bennett, Beckett, and Wilson), and Department of Neurological Sciences (Drs. Bennett, Shannon, Goetz, and Wilson), Rush University and Rush Presbyterian St. Luke's Medical Center, Chicago, IL.
K. M. Shannon, MD
From the Rush Alzheimer's Disease Center (Drs. Bennett and Wilson), Rush Institute for Healthy Aging (Drs. Bennett, Beckett, and Wilson), and Department of Neurological Sciences (Drs. Bennett, Shannon, Goetz, and Wilson), Rush University and Rush Presbyterian St. Luke's Medical Center, Chicago, IL.
L. A. Beckett, PhD
From the Rush Alzheimer's Disease Center (Drs. Bennett and Wilson), Rush Institute for Healthy Aging (Drs. Bennett, Beckett, and Wilson), and Department of Neurological Sciences (Drs. Bennett, Shannon, Goetz, and Wilson), Rush University and Rush Presbyterian St. Luke's Medical Center, Chicago, IL.
C. G. Goetz, MD
From the Rush Alzheimer's Disease Center (Drs. Bennett and Wilson), Rush Institute for Healthy Aging (Drs. Bennett, Beckett, and Wilson), and Department of Neurological Sciences (Drs. Bennett, Shannon, Goetz, and Wilson), Rush University and Rush Presbyterian St. Luke's Medical Center, Chicago, IL.
R. S. Wilson, PhD
From the Rush Alzheimer's Disease Center (Drs. Bennett and Wilson), Rush Institute for Healthy Aging (Drs. Bennett, Beckett, and Wilson), and Department of Neurological Sciences (Drs. Bennett, Shannon, Goetz, and Wilson), Rush University and Rush Presbyterian St. Luke's Medical Center, Chicago, IL.

Notes

Address correspondence and reprint requests to Dr. David A. Bennett, Rush Institute for Healthy Aging, 1645 W. Jackson, Suite 675, Chicago, IL 60612.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia, Diabetes/Metabolism Research and Reviews, 41, 1, (2025).https://doi.org/10.1002/dmrr.70032
    Crossref
  2. Temporal Sequence of Incident Mild Cognitive Impairment, Incident Parkinsonism, and Risk of Death in Unimpaired Community-Dwelling Older Adults, The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 80, 1, (2024).https://doi.org/10.1093/gerona/glae275
    Crossref
  3. Parkinson’s Disease and Other Alzheimer’s Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults, Journal of Alzheimer's Disease, 100, s1, (S197-S209), (2024).https://doi.org/10.3233/JAD-240593
    Crossref
  4. Bradykinesia in dystonic hand tremor: kinematic analysis and clinical rating, Frontiers in Human Neuroscience, 18, (2024).https://doi.org/10.3389/fnhum.2024.1395827
    Crossref
  5. Physical rehabilitation for Parkinson’s disease: assessment and treatment preferences of physical therapists, Physiotherapy Quarterly, 31, 4, (70-80), (2023).https://doi.org/10.5114/pq.2023.125165
    Crossref
  6. Explainable deep learning approach for extracting cognitive features from hand-drawn images of intersecting pentagons, npj Digital Medicine, 6, 1, (2023).https://doi.org/10.1038/s41746-023-00904-w
    Crossref
  7. Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults, Neurology, 101, 7, (e754-e763), (2023)./doi/10.1212/WNL.0000000000207497
    Abstract
  8. Correlates of Person-Specific Rates of Change in Sensor-Derived Physical Activity Metrics of Daily Living in the Rush Memory and Aging Project, Sensors, 23, 8, (4152), (2023).https://doi.org/10.3390/s23084152
    Crossref
  9. Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts, Journal of Parkinson’s Disease, 13, 4, (525-536), (2023).https://doi.org/10.3233/JPD-223256
    Crossref
  10. Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population, npj Parkinson's Disease, 9, 1, (2023).https://doi.org/10.1038/s41531-023-00454-8
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share